Cured II - LENT Cancer Survivorship Research And Education

- The ABCDs of the CURED Biocontinuum

- Conceptual Frameworks, Theories, Models, and Methodologic Issues

- Biodetection and Biointervention: Cytokine Pathways as a Rationale for Anticytokine Interventions Post-Radiation

- Bioimaging in Vivo to Discern the Evolution of Late Effects Temporally and Spatially

- The Potential of Single Nucleotide Polymorphisms (SNPs) to Assess Host Genomics Pre- and Post-Therapy to Determine Risks for Late Effects

- Understanding Radiotherapy-Induced Second Cancers

- Bioengineering in the Repair of Irradiated Normal Tissue by Bone Marrow Derived Stem Cell Populations

- The QARC Operation to Quality Control and Evaluate Digital Data in Clinical Trials

- Screening for Second Malignant Tumors in the Gastrointestinal Tract in Patients Irradiated for Pelvic and Abdominal Cancers

- Post-Radiation Dysphagia and Dose Volume Histogram Analysis

- Lithium as a Differential Radioprotector Following Brain Irradiation

- Serial Endocrine Profiles in Survivors of CNS Tumors who have been Irradiated

- Risk Factors for Second Malignancies in Patients who Have Undergone Stem Cell Transplant

- Risks and Surveillance for Second Malignant Tumors in Prostate and Bladder Cancer Survivors

- Cardiopulmonary Injury in Survivors of Lymphoma and the Rationale for Amelioration with Exercise

- Long Term Cardiovascular Complications in Hodgkin Lymphoma Post Combined Modality Treatment

- Equal Treatment Results in Equal Outcomes: Does Race Influence the Susceptibility to Late Effects Following Cancer Therapy?.-Cross-Linkages in Radiation Bioterror and Cancer Survivorship Late Effects Research.-CONCURED: Defining the Leading Edge in Research of Adverse Effects of Cancer Treatment

- Subject Index

- List of Contributors